# Tatsuya Yamashita

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/tatsuya-yamashita/

## Facts

| Field | Value |
| --- | --- |
| Citations | 17,469 |
| Field | Hepatocellular Carcinoma Treatment and Prognosis |
| h-index | 63 |
| i10-index | 181 |
| Last Known Institution | Tokyo Metropolitan Police Hospital |
| OpenAlex ID | https://openalex.org/A5086023651 |
| ORCID iD | https://orcid.org/0000-0002-3602-8086 |
| Works | 398 |

## Researcher papers

- [Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial](https://scholariq.org/papers/pembrolizumab-in-patients-with-advanced-hepatocellular-carcinoma-previously/)
- [A Liver-Derived Secretory Protein, Selenoprotein P, Causes Insulin Resistance](https://scholariq.org/papers/a-liver-derived-secretory-protein-selenoprotein-p-causes-insulin-resistance/)
- [Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial](https://scholariq.org/papers/combination-gemcitabine-plus-s-1-versus-gemcitabine-plus-cisplatin-for-advanced/)
- [Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 trial](https://scholariq.org/papers/lenvatinib-versus-sorafenib-for-first-line-treatment-of-unresectable/)

## Researcher topics

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Hepatitis C virus research](https://scholariq.org/topics/hepatitis-c-virus-research/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)

## Researcher university

- [Tokyo Metropolitan Police Hospital](https://scholariq.org/institutions/tokyo-metropolitan-police-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.